Suppliers / Curia

Curia

Spain reconciled across 16 public records · 8 entities Updated 9 July 2026

Curia is an API and finished-dose manufacturer based in Spain. It holds 116 active US drug master files and 8 valid CEPs. Its filings concentrate with MINSA (CR) and NCELS (KZ). Its GMP standing is certified by ANSM (FR), US FDA and EDQM, among 5 authorities. Its most recent recorded inspection, by US FDA, closed on 5 February 2026 as OAI.

116
active US DMFs
8
valid CEPs
19
registered plants 10 with an FDA FEI number
8
filings across 2 regulators
These figures were checked against the regulators' own files on 25 July 2026
Plants
1 of 1 confirmed
Inspections
8 of 8 confirmed
Sources: FDA Establishment Registration, read 4 May 2026. FDA drug inspection classifications, read 4 May 2026.

Inspection history

  • 5 February 2026 OAI US FDA
  • 2 December 2025 NAI US FDA
  • 28 June 2024 VAI US FDA
  • 16 February 2024 VAI US FDA
  • 1 November 2023 VAI US FDA
  • 27 February 2023 VAI US FDA
  • 24 February 2023 VAI US FDA
  • 17 November 2022 NAI US FDA
  • 16 September 2022 VAI US FDA
  • 3 March 2022 VAI US FDA
  • 8 October 2021 VAI US FDA
  • 20 March 2020 VAI US FDA

NAI means no action indicated, VAI means voluntary action indicated, and OAI means official action indicated.

Registered plants

Site FDA FEI
Valladolid, Spain Not on file
Spain, Spain 3002996872
Bon-Encontre, France Not on file
BON ENCONTRE, France Not on file
TONNEINS, France Not on file
Tonneins, France Not on file

13 further sites are on record.

What they file, and where

Molecule Regulators Docs
Aztreonam US FDA 5
Amphetamine US FDA 3
Dextroamphetamine US FDA 3
Hydrocortisone US FDA 3
Minocycline EDQM, US FDA 3
(21R)-Argatroban US FDA 2
Betamethasone US FDA 2
Budesonide US FDA 2
Cyclosporine US FDA 2
Dorzolamide SFDA (Saudi Arabia), US FDA 2
Show all 40 molecules on file
Flutamide EDQM, US FDA 2
Mecamylamine US FDA 2
Methylprednisolone US FDA 2
Olopatadine US FDA 2
Propofol EDQM, US FDA 2
Ribavirin EDQM, US FDA 2
Rocuronium SFDA (Saudi Arabia), US FDA 2
Alcaftadine US FDA 1
Alclometasone US FDA 1
Altrenogest US FDA 1
Atropine US FDA 1
Azelastine US FDA 1
Betamethasone Dipropionate SFDA (Saudi Arabia) 1
Brexanolone US FDA 1
Bromocriptine US FDA 1
Cannabidiol US FDA 1
Carbimazole EDQM 1
Chlortalidone EDQM 1
Chlorthalidone US FDA 1
Choline Fenofibrate US FDA 1
Clobetasol Propionate US FDA 1
Deoxycholic Acid US FDA 1
Desogestrel US FDA 1
Deucravacitinib US FDA 1
Dexamethasone US FDA 1
Dexmethylphenidate US FDA 1
Diethylamine Salicylate SFDA (Saudi Arabia) 1
Dihydroergotamine US FDA 1
Echothiophate US FDA 1
Epinephrine US FDA 1

Also appears on these molecule pages

Show 24 more molecule pages

Filings and GMP by regulator

Regulator Filings GMP certificates
MINSA (CR) 7 None
NCELS (KZ) 1 None
ANSM (FR) None 40
US FDA None 3
EDQM None 2
MFDS (Korea) None 2
AEMPS (ES) None 2

Questions about Curia

Does Curia hold a US DMF or a CEP?
Curia holds 116 active US drug master files and 8 valid CEPs. A drug master file is a submission to the FDA describing how an ingredient is made; a CEP is the EDQM's certificate that the substance meets its European Pharmacopoeia monograph. Both are filings rather than approvals.
Is Curia FDA-registered?
10 sites operated by Curia carry an FDA establishment identifier (FEI), which means they are registered with the FDA as a drug establishment. Registration is not the same as approval or inspection clearance.
How did Curia's last inspection go?
The most recent inspection on record closed on 5 February 2026 as OAI (Official Action Indicated, the worst classification: objectionable conditions were found and regulatory action was warranted). 24 inspections are on file, of which 1 closed as OAI.
Where does Curia manufacture?
19 registered sites are on record, in Spain, France, India and Italy (Valladolid, Spain and Bon-encontre among others). Every site is listed on this page with the register it came from.
What does Curia make?
40 molecules are on record against Curia, including Aztreonam, Amphetamine, Dextroamphetamine and Hydrocortisone. Each links through to that molecule's full manufacturer list.
Which regulators recognise Curia's GMP?
Current GMP certificates are on record from ANSM (FR), US FDA, EDQM, MFDS (Korea) and AEMPS (ES). GMP recognition covers the manufacturing site, separately from any filing on the substance itself.

Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.

Comparing suppliers?

Choose your molecules and target markets. Curia comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Open risk flags

  • 2 active litigation matters are on record.
  • The most recent inspection outcome was OAI, on 5 February 2026.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability
EudraGMDP and national regulators
GMP certificates